Science Focus
Science and Innovation - Human Health Innovation - Science Focus
Search
Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada
Aservo™ EquiHaler™, industry-first therapy for severe equine asthma, now available in Canada
History
History
Featured Articles
Featured Articles
Vision & values
Boehringer Ingelheim employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) More than 25 billion EUR investment in R&D and 7 billion EUR in capital expenditure over the next five years Human Pharma pipeline acceleration: up to 15 new product launches
Animal Health Products
Animal Health Products
Therapeutics
Science and Innovation - Animal Health Innovation - Therapeutics
Medicine & Regulatory Affairs
Medicine & Regulatory Affairs
Poultry
Poultry
Corporate profile
Corporate profile
Animal Health Partnering Interests
In order to create the next generation of medical breakthroughs in animal health we need partners. Click here to view our animal health partnering interests.
Home Health Monitoring
Read more about the HHM Project that provides a community-based home health monitoring digital solution for people living with chronic conditions.
Ensho Health
Boehringer Ingelheim Canada, community cardiologists, and Ensho Health collaborated to create a tool optimizing care for chronic conditions in Alberta. More info.
Sustainable Development - Our Commitment
Our Commitment
Financial health
We constantly review our salaries to make sure they stay competitive in each market but we also provide wider support for financial health.
Pets
Pets
New collaboration to improve the detection of type 2 diabetes in high-risk patients starts in Montreal, Quebec
The project will use artificial intelligence (A.I.), wearable technologies and electronic health record systems to identify patients who may have type 2 diabetes in Montreal, Quebec
Purchasing
Purchasing at Boehringer Ingelheim
Science Stories
Science and Innovation - Human Health Innovation - Science Stories
Grass Roots
Science and Innovation - Human Health Innovation - Grass Roots
More Potential
Boehringer Ingelheim steps up its commitment to sustainable development, building on its historical success in addressing unmet health needs and increasing its ambitions to tackle global health and societal challenges.
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
Salmonella in pigs, pork and people
Salmonella in pigs, pork and people
COVID-19
COVID-19